Forian Inc.
$0
▲
0.46%
2026-07-25 08:04:01
forian.com
NCM: FORA
Explore Forian Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$64.01 M
Current Price
$0
52W High / Low
$5.45 / $1.87
Stock P/E
—
Book Value
$0.96
Dividend Yield
—
ROCE
-8.29%
ROE
-9.43%
Face Value
—
EPS
$-0.09
Exp Qtr EPS
—
Sector
Healthcare
FORA — Monthly Price History
Adjusted close price · Hover to see price & month
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Veeva Systems Inc. | $186.24 | 32.08 | $30.21 B | — | 12.48% | 13.36% | $310.5 / $148.05 | $44.05 |
| 2. | BrightSpring Health Services, Inc. | $66.25 | 86.04 | $13 B | — | — | 0.09% | $66.69 / $19.01 | $9.66 |
| 3. | HealthEquity, Inc. | $94.64 | 34.18 | $7.89 B | — | 10.16% | 10.94% | $105.96 / $72.76 | $24.79 |
| 4. | Tempus AI, Inc. | $42.69 | — | $7.69 B | — | -13.29% | -70.24% | $104.32 / $41.73 | $2.76 |
| 5. | Hinge Health, Inc. | $74.31 | — | $5.93 B | — | -142.9% | -138.7% | $91.5 / $30.08 | $4.78 |
| 6. | 10x Genomics, Inc. | $46.27 | — | $5.93 B | — | -12.49% | -2.86% | $49.5 / $11.16 | $6.24 |
| 7. | Waystar Holding Corp. | $22.51 | 33.6 | $4.24 B | — | 4.48% | 3.55% | $41.47 / $17.26 | $20.25 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 7.96 M | 7.76 M | 7.48 M | 7.06 M | 5.81 M | — |
| Operating Profit | -0.83 M | -0.3 M | 0.05 M | -1.39 M | -1.17 M | — |
| Net Profit | -1.82 M | -0.15 M | 0.22 M | -1.13 M | 0.2 M | — |
| EPS in Rs | -0.06 | -0 | 0.01 | -0.04 | 0.01 | -0.01 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 30.26 M | 20.15 M | 21.22 M | 16.42 M |
| Operating Profit | -2.47 M | -5.56 M | -3.3 M | -13.54 M |
| Net Profit | -2.87 M | -3.77 M | 11.77 M | -25.97 M |
| EPS in Rs | -0.09 | -0.12 | 0.38 | -0.83 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 44.13 M | 47.17 M | 60.41 M | 46.26 M |
| Total Liabilities | 14.35 M | 17.12 M | 32.69 M | 33.84 M |
| Equity | 29.78 M | 30.05 M | 27.72 M | 12.42 M |
| Current Assets | 42.56 M | 44.46 M | 58.8 M | 26.92 M |
| Current Liabilities | 14.35 M | 16.6 M | 6.82 M | 8.35 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.89 M | 0.28 M | 0.73 M | -8.58 M |
| Investing CF | 12.94 M | 17.29 M | 7.12 M | -6.46 M |
| Financing CF | -7.52 M | -19.02 M | -4.6 M | -0.1 M |
| Free CF | 2.89 M | 0.28 M | 0.65 M | -8.63 M |
| Capex | — | — | -0.08 M | -0.05 M |
5Y Margin & Growth History
Last 5 years of annual financial statement data.
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -5.01% | 29.23% | — | — |
| Earnings Growth % | -132.04% | 145.31% | — | — |
| Profit Margin % | -18.71% | 55.47% | -158.19% | — |
| Operating Margin % | -27.59% | -15.55% | -82.44% | — |
| Gross Margin % | 63.61% | 74.19% | 69.24% | — |
| EBITDA Margin % | -14.44% | 16.08% | -111.19% | — |
Dividend & Split History
Latest dividend payments and stock split events.
Dividend History
No dividend history available.
Stock Splits
No stock split history available.